The Bill Nobody's Discussing in the Exam Room

Head and neck cancer costs are crushing patients — yet cost discussions remain uncommon in clinical care.

1

Only 15% of cancer patients have financial discussions with their care team, despite over 90% wanting such conversations.
2

Head and neck cancer treatment is costly, often requiring multimodal approaches that increase overall expenses.
3

Cost conversations in oncology are linked to lower out-of-pocket costs, better treatment adherence, and higher patient satisfaction.
4

Patients from disadvantaged backgrounds are less likely to initiate financial discussions, risking their financial hardships being overlooked.
5

Routine financial screening in clinical practice is recommended to improve patient care and reduce stigma associated with financial concerns.

1